Skip to the page

Data / Form D filings / Bioverge, Inc.

Bioverge, Inc.: Form D filings

Bioverge, Inc., a technology company in San Francisco, CA, filed 3 Form D notices with the SEC in 2023. The latest, on May 8, 2023, reports $148,500 sold of a $148,500 offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
447 Sutter St. Ste 405, San Francisco, CA, 94108
Phone
(866) 415-1001
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1828649

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 8, 2023New notice$148,500$148,5004Mar 7, 2022sec.gov
May 5, 2023New notice$775,000$775,00021May 5, 2020sec.gov
May 4, 2023New notice$600,000$588,500$11,50023Dec 3, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Neil LittmanExecutive Officer, Director
Richard GibbExecutive Officer

Other technology companies in California that filed recently

Every Form D from the week of May 8, 2023 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Bioverge, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.